跳至主要内容
临床试验/NCT06149312
NCT06149312Unknown不适用

A Prospective, Randomized Trial Assessing the Feasibility of an Advance Care Planning Intervention for Patients Hospitalized in a French Cancer Center

Institut de cancérologie Strasbourg Europe1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2023年12月29日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
120
试验地点
1
主要终点
Percentage of patients who write advance directives of living at 3 months

研究概览

简要总结

Advanced Cancer patients hospitalized in a Cancer center inpatient unit have a dismal prognosis. Palliative Care interventions have shown multiple benefit for those patients, regarding quality of life, symptom management, illness understanding and aggressiveness of care criteria. Although Advance Care planning (ACP) is part of usual Palliative Care, specific interventions dedicated to ACP are understudied.

This study aims at showing that a simple and systematic Advance Care Planning intervention is likely to clarify the understanding of the goals of care by patients, to help with ACP documentation and and potentially to modify the trajectory of illness for patients during and after hospitalization.

详细描述

PREVOIR is a randomized, single-center, two-arm trial: patients from experimental arm will benefit from a systematic interview on the care plan whereas patients from control arm will received standard cares.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Patients aged 18 years or older
  • •Patients with a diagnosis of advanced or metastatic solid cancer
  • •Patients hospitalized in a conventional oncology, radiotherapy or hematology department
  • •Agreement obtained from the referring oncologist or senior doctor responsible for the patient during hospitalization
  • •Patient hospitalized for less than 7 days
  • •Patients who have not yet written advance directives
  • •Signature of informed consent

排除标准

  • •Patients treated for hematologic malignancies
  • •Presence of uncontrolled symptoms that do not allow an interview to be carried out
  • •Patients with planned hospitalization for chemotherapy or biopsy or performance of a procedure
  • •Patients < 18 years old or patients ≥ 18 years old under supervision
  • •Patients placed under judicial protection or guardianship
  • •Decompensated neuropsychiatric disorders
  • •Comprehension problems
  • •Patients without social security
  • •Allophone patients

研究组 & 干预措施

Advance Care Planning Intervention

Experimental

Patients from experimental arm will benefit from a Standardized Advance Care Planning interview alone or in the presence of relatives within 3 days after randomization.

干预措施: Advance Care Planning Intervention (Other)

Standard cares

No Intervention

Patients from control arm will be treated without specific intervention, which does not exclude the possibility of resorting to non standardized advance care planning interviews with an oncologist or a physician specialized in palliative care.

结局指标

主要结局

Percentage of patients who write advance directives of living at 3 months

时间窗: At 3 months from randomization

次要结局

  • Percentage of patients who write advance directives of living at 1 month(At 1 month from randomization)
  • Overall survival(Up to 6 months)
  • Percentage of patients who write advance directives of living at 6 months(At 6 months from randomization)
  • Received anti-cancer treatment(up to 6 months)
  • Patients living trajectory(up to 6 months)

研究者

发起方
Institut de cancérologie Strasbourg Europe
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验